![]() |
BioSpaceAuthor: BioSpace
Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether its layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development. Language: en Genres: Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Automation, Collaboration and the Future of Advanced Therapies
Thursday, 9 April, 2026
In this episode of Denatured, you'll listen to Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. They discuss how cell and gene therapy manufacturing is facing growing pressure to scale more quickly and efficiently, driving developers and manufacturers toward automation, digitization, robotics and broader collaboration across the ecosystem.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsJason Jones, Head of Global Business Development, Cellular OriginsAlexander Seyf, Founder & CEO, AutolomousDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.











